{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-104034","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2026-09-28T20:05:33+00:00","discovered_at":"2026-09-28T20:07:06.257290+00:00","generated_at":"2026-10-12T13:35:03.560845+00:00","sec_items":["1.01","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Tempest CFO Rossettos resigns; Constance Ames named CFO; Freda-Smith joins board as Audit Chair","bullets":["Related-party Master Services Agreement with Factor Bioscience: CEO Matt Angel controls Factor and owns 34.2% of Tempest; expected fees of $5.0M/year paid in $416,667 monthly installments.","Work Order No. 1 covers development of in vivo CAR-T therapies; either party may terminate the MSA or work order on 30 days' notice; Tempest has three one-month suspension rights.","CFO Nicholas Rossettos resigned effective immediately on Sept 22, 2026; Constance Ames named CFO, principal financial and accounting officer, treasurer and corporate secretary.","Nancy Freda-Smith, 54, former Chief Audit and Risk Officer at Ralph Lauren, appointed Class III director and Chair of the Audit Committee; receives a 25,000-share option award.","Nasdaq told Tempest on May 22, 2026 it was out of compliance over multiple board vacancies; after adding Freda-Smith, Dr. Yee and Mr. Richey, the board says it is now in full compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-104034","json":"https://secwatch.observer/filing/0001213900-26-104034.json","markdown":"https://secwatch.observer/filing/0001213900-26-104034.md","text":"https://secwatch.observer/filing/0001213900-26-104034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000121390026104034/0001213900-26-104034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000121390026104034/ea0306741-8k_tempest.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:35:03.560845+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}